Skye Bioscience, Inc. Increase (Decrease) in Notes Payable, Related Parties, Current
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Notes Payable, Related Parties, Current of $11.40 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent · last filed 2020-11-06
- Skye Bioscience, Inc. increase (decrease) in notes payable, related parties, current for the quarter ending 2020-09-30 was -$55.89K.
- Skye Bioscience, Inc. increase (decrease) in notes payable, related parties, current for the quarter ending 2020-06-30 was $36.39K.
- Skye Bioscience, Inc. increase (decrease) in notes payable, related parties, current for the quarter ending 2020-03-31 was $30.90K.
- Skye Bioscience, Inc. increase (decrease) in notes payable, related parties, current for the quarter ending 2018-09-30 was -$50.00K.
| Period end | Increase (Decrease) in Notes Payable, Related Parties, Current 3 month | Increase (Decrease) in Notes Payable, Related Parties, Current 6 month | Increase (Decrease) in Notes Payable, Related Parties, Current 9 month |
|---|---|---|---|
| 2020-09-30 | -$55.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$19.50K derived: sum of 2 quarters · filed 2020-11-06 | $11.40K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $36.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $67.29K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $30.90K 10-Q · filed 2020-05-08 | ||
| 2018-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$85.00K derived: sum of 2 quarters · filed 2019-11-14 | $15.00K 10-Q · filed 2019-11-14 |
| 2018-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $65.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $100.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |